Company: APXT
Filing Date: 2025-10-28
Form Type: 424B4
Source: 0001213900-25-103160
Chunk: 154

Company: Apex Treasury Corp
Filing Date: 2025-10-28
Form: 424B4
Chunk 154
---
 full) payable to the underwriters in this offering. Upon completion of our initial business combination, up to $12,000,000 in the aggregate, (or up to $13,800,000 if the over -allotmentoption is exercised in full) which constitutes the deferred underwriting commissions will be paid to the underwriters from the remaining cash held in the Company’s trust account at the closing of the initial business combination, but any such amounts shall be due solely on amounts remaining in the trust account following all properly submitted shareholder redemptions in connection with the consummation of our initial business combination. For example, if the underwriters’ over -allotmentoption is not exercised and 25,000,000 public shares are properly submitted for redemption in connection with the consummation of our initial business combination, the deferred commission payable to the underwriters in this offering would be equal to 4.0% of the remaining 5,000,000 public shares, or $2,000,000. The remaining funds will be released to us and can be used to pay all or a portion of the purchase price of the business or businesses with which our initial business combination occurs or for general corporate purposes, including payment of principal or interest on indebtedness incurred in connection with our initial business combination, to fund the purchases of other companies, or for working capital. The underwriters will not be entitled to any interest accrued on the deferred underwriting discounts and commissions.

100

The following table shows the use of the approximately $1,300,000 of net proceeds not held in the trust account. (1)

|                                                                                                   |     | Amount |           |     | % of Total |   |
|:--------------------------------------------------------------------------------------------------|:----|:-------|----------:|:----|-----------:|:--|
| Accounting, due diligence, travel, and other expenses in connection with any business combination |     | $      |   220,000 |     |       16.9 | % |
| Legal and accounting fees related to regulatory reporting obligations                             |     | $      |   175,000 |     |       13.5 | % |
| Nasdaq and other regulatory fees                                                                  |     | $      |    75,000 |     |        5.8 | % |
| Reimbursement for administrative support(2)                                                       |     | $      |   420,000 |     |       32.3 | % |
| Directors’ and officers’ liability